Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 657

1.

Toll-like receptor 9 in systemic sclerosis patients: relation to modified Rodnan skin score, disease severity, and functional status.

Gheita TA, Sayed S, Azkalany GS, Abaza N, Hammam N, Eissa AH.

Clin Rheumatol. 2018 Mar;37(3):757-763. doi: 10.1007/s10067-017-3880-6. Epub 2017 Oct 26.

PMID:
29076114
2.

Association between TLR-9 gene rs187084 polymorphism and knee osteoarthritis in a Chinese population.

Zheng M, Shi S, Zheng Q, Wang Y, Ying X, Jin Y.

Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170844. doi: 10.1042/BSR20170844. Print 2017 Oct 31.

3.

Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.

Chandler MR, Keene KS, Tuomela JM, Forero-Torres A, Desmond R, Vuopala KS, Harris KW, Merner ND, Selander KS.

PLoS One. 2017 Sep 8;12(9):e0183832. doi: 10.1371/journal.pone.0183832. eCollection 2017.

4.

TLR9 gene polymorphism -1486T/C (rs187084) is associated with uterine cervical neoplasm in Mexican female population.

Martínez-Campos C, Bahena-Román M, Torres-Poveda K, Burguete-García AI, Madrid-Marina V.

J Cancer Res Clin Oncol. 2017 Dec;143(12):2437-2445. doi: 10.1007/s00432-017-2495-2. Epub 2017 Aug 17.

PMID:
28819773
5.

UV Radiation Activates Toll-Like Receptor 9 Expression in Primary Human Keratinocytes, an Event Inhibited by Human Papillomavirus 38 E6 and E7 Oncoproteins.

Pacini L, Ceraolo MG, Venuti A, Melita G, Hasan UA, Accardi R, Tommasino M.

J Virol. 2017 Sep 12;91(19). pii: e01123-17. doi: 10.1128/JVI.01123-17. Print 2017 Oct 1.

6.

Rapid Complexation of Aptamers by Their Specific Antidotes.

Stoll H, Steinle H, Wilhelm N, Hann L, Kunnakattu SJ, Narita M, Schlensak C, Wendel HP, Avci-Adali M.

Molecules. 2017 Jun 8;22(6). pii: E954. doi: 10.3390/molecules22060954.

7.

Plasma-derived exosomes contribute to inflammation via the TLR9-NF-κB pathway in chronic heart failure patients.

Ye W, Tang X, Yang Z, Liu C, Zhang X, Jin J, Lyu J.

Mol Immunol. 2017 Jul;87:114-121. doi: 10.1016/j.molimm.2017.03.011. Epub 2017 Apr 25.

PMID:
28433888
8.

Toll-like receptors genes polymorphisms and the occurrence of HCMV infection among pregnant women.

Wujcicka W, Paradowska E, Studzińska M, Wilczyński J, Nowakowska D.

Virol J. 2017 Mar 24;14(1):64. doi: 10.1186/s12985-017-0730-8.

9.

Association between TLR9 rs5743836 polymorphism and risk of recurrent venous thromboembolism.

Ahmad A, Sundquist K, Zöller B, Svensson PJ, Sundquist J, Memon AA.

J Thromb Thrombolysis. 2017 Jul;44(1):130-138. doi: 10.1007/s11239-017-1491-3.

10.

Promoter polymorphism (T-1486C) of TLR-9 gene is associated with knee osteoarthritis in a Turkish population.

Balbaloglu O, Sabah Ozcan S, Korkmaz M, Yılmaz N.

J Orthop Res. 2017 Nov;35(11):2484-2489. doi: 10.1002/jor.23559. Epub 2017 Mar 29.

11.

High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients.

Leppänen J, Helminen O, Huhta H, Kauppila JH, Isohookana J, Haapasaari KM, Lehenkari P, Saarnio J, Karttunen TJ.

Virchows Arch. 2017 Apr;470(4):401-410. doi: 10.1007/s00428-017-2087-1. Epub 2017 Feb 12.

PMID:
28191612
12.

Selectivity of Human TLR9 for Double CpG Motifs and Implications for the Recognition of Genomic DNA.

Pohar J, Yamamoto C, Fukui R, Cajnko MM, Miyake K, Jerala R, Benčina M.

J Immunol. 2017 Mar 1;198(5):2093-2104. doi: 10.4049/jimmunol.1600757. Epub 2017 Jan 23.

13.

Cell membrane and intracellular expression of toll-like receptor 9 (TLR9) in colorectal cancer and breast cancer cell-lines.

Shahriari S, Rezaeifard S, Moghimi HR, Khorramizadeh MR, Faghih Z.

Cancer Biomark. 2017;18(4):375-380. doi: 10.3233/CBM-160260.

PMID:
28106541
14.

Evaluation of TLR9 expression on PBMCs and CpG ODN-TLR9 ligation on IFN-α production in SLE patients.

Mortezagholi S, Babaloo Z, Rahimzadeh P, Namdari H, Ghaedi M, Gharibdoost F, Mirzaei R, Bidad K, Salehi E.

Immunopharmacol Immunotoxicol. 2017 Feb;39(1):11-18. doi: 10.1080/08923973.2016.1263859. Epub 2017 Jan 3.

PMID:
28049380
15.

The role of TLR9 in stress-dependent autophagy formation.

Lim JS, Kim HS, Nguyen KC, Cho KA.

Biochem Biophys Res Commun. 2016 Dec 9;481(3-4):219-226. doi: 10.1016/j.bbrc.2016.10.105. Epub 2016 Oct 26.

PMID:
27793667
16.

Impaired toll like receptor 9 response in pulmonary tuberculosis.

Ramakrishna K, Premkumar K, Kabeerdoss J, John KR.

Cytokine. 2017 Feb;90:38-43. doi: 10.1016/j.cyto.2016.10.006. Epub 2016 Oct 18.

PMID:
27768958
17.

The role of Toll-like receptor 9 in gynecologic cancer.

Fehri E, Ennaifer E, Bel Haj Rhouma R, Guizani-Tabbane L, Guizani I, Boubaker S.

Curr Res Transl Med. 2016 Jul - Sep;64(3):155-159. doi: 10.1016/j.retram.2016.01.010. Epub 2016 Mar 4. Review.

PMID:
27765276
18.

Tumor Location and Survival Outcomes in Adult Patients with Supratentorial Glioblastoma by Levels of Toll-Like Receptor 9 Expression.

Mu L, Wang Y, Wang Y, Zhang H, Shang D, Tan F, Li Y, Chen X.

World Neurosurg. 2017 Jan;97:279-283. doi: 10.1016/j.wneu.2016.10.015. Epub 2016 Oct 12.

PMID:
27744078
19.

TLR9 mediates S. aureus killing inside osteoblasts via induction of oxidative stress.

Mohamed W, Domann E, Chakraborty T, Mannala G, Lips KS, Heiss C, Schnettler R, Alt V.

BMC Microbiol. 2016 Oct 3;16(1):230.

20.

Analysis of Toll-like Receptor 9 Gene Polymorphisms in Sepsis.

Atalan N, Karagedik H, Acar L, Isbir S, Yilmaz SG, Ergen A, Isbir T.

In Vivo. 2016 09-10;30(5):639-43.

PMID:
27566084

Supplemental Content

Support Center